News | April 25, 2013

Toshiba Partners With Leading Universities for Advanced MR Research

Introduces new sequence development environment at ISMRM

April 25, 2013 — Leading research institutions are making breakthroughs in advanced magnetic resonance (MR) imaging with Toshiba America Medical Systems Inc.’s Vantage Titan 3.0T MR system. Toshiba has partnered with Shands at the University of Florida and the Keck Medical Center of the University of Southern California (USC) for MR clinical research in functional MRI (fMRI), as well as body and cardiac imaging.

 “We’re utilizing the Titan 3.0T MR to enhance visualization of cerebral spinal fluid (CSF) flow non-invasively and in the research of traumatic brain injuries from combat and athletics,” said Anthony Mancuso, professor and chairman of the department of radiology, UF College of Medicine. “The Titan 3.0T fulfills all the promises of a high-end 3.0T system, with high image quality, gradient homogeneity and patient-focused features.”

As part of Toshiba’s commitment to supporting institutions in advanced MR research, Toshiba is demonstrating the new sequence development environment (NSDE), a research-only tool that allows the research community to develop its own pulse sequences to explore new applications of MR imaging.

“Partnering with prestigious universities such as USC and Shands at the University of Florida illustrates our commitment to developing advanced technology that can expand the potential clinical applications of MR imaging,” said Suresh Narayan, senior manager, market development, MR business unit, Toshiba.

Toshiba showcased the Titan 3.0T with NSDE at this year’s International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting in Salt Lake City, April 20-26, 2013.

For more information: www.medical.toshiba.com


Related Content

News | Cardiovascular Clinical Studies

May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...

Home May 06, 2026
Home
News | Cardiovascular Clinical Studies

April 9, 2026 — Mount Sinai researchers have created an analytic tool using machine learning that can predict ...

Home April 14, 2026
Home
News | Cardiovascular Clinical Studies

April 13, 2026 —The American Heart Association (AHA) has granted Case Western Reserve University the Rapid Impact ...

Home April 13, 2026
Home
News | Cardiovascular Clinical Studies

April 2, 2026 — Iterative Health and US Heart & Vascular (USHV) have announced a strategic partnership to advance ...

Home April 02, 2026
Home
News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
Subscribe Now